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Managing patients with multimorbidity in primary care
Emma Wallace general practice lecturer 1, Chris Salisbury professor in primary health care 2, Bruce
Guthrie professor of primary care medicine 3, Cliona Lewis general practice lecturer 1, Tom Fahey
professor of general practice 1, Susan M Smith associate professor of general practice 1
1HRB Centre for Primary Care Research, Royal College of Surgeons in Ireland Medical School, Dublin 2, Ireland; 2Centre for Academic Primary
Care, University of Bristol, Bristol, UK; 3Quality, Safety and Informatics Research Group, University of Dundee, Dundee, UK
Multimorbidity, commonly defined as the presence of two or
more chronic medical conditions in an individual,1 is associated
with decreased quality of life, functional decline, and increased
healthcare utilisation, including emergency admissions,
particularly with higher numbers of coexisting conditions.2-6
Themanagement of multimorbidity with drugs is often complex,
resulting in polypharmacy with its attendant risks.7-9 Patients
with multimorbidity have a high treatment burden in terms of
understanding and self managing the conditions, attending
multiple appointments, andmanaging complex drug regimens.10
Qualitative research highlights the “endless struggle” patients
experience in trying to manage their conditions well.11
Psychological distress is common: in an Australian survey of
7620 patients in primary care, 23% of those with one chronic
condition reported depression compared with 40% of those with
five or more conditions.12
Multimorbidity presents many challenges, which may at times
seem overwhelming. This review provides evidence based
practice points that are feasible to implement in general practice
and offers guidance for general practitioners in organising care
delivery.
How common is it?
Recent estimates suggest that one in six patients in the United
Kingdom has more than one of the conditions outlined in the
Quality and Outcomes Framework, and these patients account
for approximately one third of all consultations in general
practice.13 A recent, large scale Scottish study reported that
approximately 65% of those agedmore than 65 years and almost
82% of those aged 85 years or more had two or more chronic
conditions.14 Although prevalence increases substantially with
age, in absolute terms multimorbidity is more prevalent in those
aged 65 years or less and is much more common in
socioeconomically deprived areas.14A recent systematic review
included 11 studies relating to patterns of multimorbidity. The
most common pair of conditions across studies was osteoarthritis
and a cardiometabolic condition, such as hypertension, diabetes,
obesity, or ischaemic heart disease.15 This review also attempted
to identify meaningful groups of conditions. In four studies that
used factor analysis to identify common factors across
combinations of conditions, three were consistent across studies;
a cardiometabolic condition factor, a mental health condition
factor (most commonly depression or anxiety), and a painful
condition factor.15
What is the impact of multimorbidity?
Box 1 summarises some commonly encountered problems for
patients with multimorbidity. In a recent systematic review,
general practitioners identified four areas where they experience
difficulties in caring for patients with multimorbidity:
disorganisation and fragmentation of care, inadequacy of current
disease specific guidelines, challenges in delivering patient
centred care, and barriers to shared decision making (box 2).16
General practitioners also highlighted the sense of professional
isolation they experience in managing these patients.
What are the challenges of chronic
disease management in multimorbidity?
Inadequacy of single disease clinical
guidelines
Managing several chronic conditions with the current single
disease focus of clinical guidelines and research is a challenge
general practitioners face daily. Guidelines rarely deal with
comorbidity, in part because they are designed to be based on
evidence from randomised controlled trials and because trials
routinely exclude older people and people with multiple chronic
conditions.23-25 This leads to a situation where every individual
recommendation made by a guideline may be rational and
evidence based, but the sum of all recommendations in an
individual is not. Consider the application of five UK clinical
guidelines for a hypothetical 78 year old woman with previous
myocardial infarction, type 2 diabetes, osteoarthritis, chronic
obstructive pulmonary disease, and depression.26 She would be
prescribed a minimum of 11 drugs, with potentially up to 10
others recommended depending on symptoms and progression
of disease, and she would be advised to engage in at least nine
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The bottom line
Multimorbidity is commonly defined as the presence of two or more chronic medical conditions in an individual and it can present several
challenges in care particularly with higher numbers of coexisting conditions and related polypharmacy
Practices should actively identify patients with complex multimorbidity and adopt a policy of continuity of care for these patients by
assigning them a named doctor
The adoption of a policy for routine extended consultations should be considered for particularly complex patients or the introduction of
occasional “specific extended consultations.” allowing protected time to deal with problems encountered in the management of chronic
diseases
Sources and selection criteria
We based this article on the authors’ experience and information from published literature. We carried out searches of PubMed and the
Cochrane library using the search terms “co-morbidity” or “comorbidity” or “multimorbid” or “multimorbidity” or “multi-morbidity”. No MeSH
term exists for multimorbidity. The searches were supplemented by a review of authors’ personal archives as well as relevant articles from
the International Research Community on Multimorbidity archive at the University of Sherbrooke, Quebec, Canada (http://crmcspl-blog.
recherche.usherbrooke.ca/?page_id=248).
Box 1: Problems commonly experienced by patients with multimorbidity
Fragmentation and poor coordination of care
Results from seeing multiple health professionals in primary and secondary care.16 17
Polypharmacy
Attendant risk of adverse drug events, potentially inappropriate prescribing, and problems with drug concordance7 18
Treatment burden
Results from the necessity of learning about and adhering to management plans and lifestyle changes suggested for different conditions
and engaging with multiple healthcare professionals19
Mental health difficulties
Anxiety and depression are more common in patients with multimorbidity and can impact on patients’ ability to manage other long term
conditions2 12
Patients living in deprived areas are particularly vulnerable to multimorbidity that includes mental health conditions 20
Those with cognitive impairment are also particularly vulnerable and may have added difficulties in managing their conditions21
Functional difficulties
Functional difficulties increase with increasing number of conditions and in people aged more than 75 years5 6
Reduced quality of life
Associated with the number of chronic medical conditions6
Increased healthcare utilisation
Includes an increased risk of emergency admission to hospital4 22
Box 2: Practice points for dealing with challenges in caring for patients with multimorbidity
Disorganisation and fragmentation of care
Identify patients as having complex multimorbidity and adopt a practice policy of continuity of care by assigning them a named doctor
Chronic disease management
Some evidence supports focusing on functional optimisation of patients with multimorbidity and on shared risk factors for several
conditions, such as blood pressure and smoking cessation
In the absence of meaningful clinical guidelines, clinical judgment is especially important in the decision making process
Medicines management
Plan regular reviews (at least annually) of drugs (explicit prescribing tools for potentially inappropriate prescribing may be useful in
reviewing polypharmacy)
Promoting patient centred care
Shared decision making—asking patients at the outset of a consultation “What is bothering you most?” or “What would you like to focus
on today?” can help prioritise management to those aspects of care that will have the most impact on patients
Self management of multimorbidity—research to date is mixed about the benefit of self management, but it may be an option for patients
expressing an interest in group based support
Short consultation times
Consider adopting a practice policy of routine extended consultations for particularly complex patients or introducing occasional “specific
extended consultations,” allowing protected time to deal with problems encountered in the management of chronic diseases
Ensure practice systems are in place to maximise the value of the general practice consultation for both patient and doctor in reaching
management decisions—for example, by seeing the practice nurse ahead of an appointment with the doctor
Arrange multidisciplinary team involvement, where appropriate
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lifestyle modifications. In addition to any unplanned
appointments, she would be expected to annually attend 8-10
routine primary care appointments for her physical conditions
and 8-30 psychosocial intervention appointments for depression
and advised to attend multiple appointments for smoking
cessation support and pulmonary rehabilitation.26
One potential solution is for future developers of guidelines to
consider addressing more common clusters of chronic
conditions.27 Although this is an important step, guidelines to
cover all combinations of conditions are unlikely and so the
value of clinical judgment should be recognised and supported.28
At times clinical judgment may mean an acceptance that in
certain circumstances pursuing stringent disease specific targets
is unlikely to be beneficial and may in fact be harmful.
Alternatively it may mean prioritising the treatment of
depression, which has been shown to impact the ability of
patients to manage their other chronic conditions.29 Policy
makers who base performance related payments on disease
specific targets need to be aware that such trade-offs based on
clinical judgment may represent better patient centred care.
Other performance measures that truly capture quality of care
for this patient group should be considered.
Targeting function not disease
The Cochrane systematic review of community based
interventions to improve outcomes for patients with
multimorbidity identified only 10 randomised controlled trials.30
Of these, six involved changes to the organisation of care
delivery, usually through case management, and the remaining
four interventions were predominantly patient oriented,
including support for self management. Although results were
mixed, interventions directed towards particular risk factors
shared across comorbid conditions or generic functional
difficulties experienced by patients seem promising. One
randomised controlled trial delivered by occupational therapists
and physiotherapists targeted functional difficulties of 319
patients aged 70 years or older with multimorbidity and
improved health outcomes including a statistically significant
reduction in mortality two years post-intervention. This
highlights the potential importance of a multidisciplinary
approach in management and a focus on generic outcomes
relevant across conditions.31
Medicines management
A recent study of 180 815 adults in primary care reported that
approximately 20% of patients with two conditions were
prescribed four to nine drugs and 1% were prescribed 10 or
more drugs.32 For patients with at least six conditions, these
values increased to 48% and 42%, respectively. Polypharmacy
is associated with drug related morbidity such as adverse drug
events, potentially inappropriate prescribing, and reduced drug
adherence.8 The prevalence of polypharmacy is increasing,
owing largely to changes in population demographics and
increasing multimorbidity.
A major difficulty for general practitioners is that many
prescriptions are initiated by specialists but repeat prescribing
occurs in primary care.8 Without clear communication it can be
difficult to judge the rationale of drug treatment. Optimising
drug regimens is an important component of care, and to achieve
this regular drug reviews are required for patients with
multimorbidity.8 The evidence for pharmacist led drug reviews
for complex polypharmacy in the community is mixed.33-35Close
collaboration between pharmacists and doctors seems the most
sensible approach for this patient group.
Drug reviews should encompass “deprescribing,” which involves
stopping drugs that are not indicated, have inadequate prognostic
benefit, or are causing side effects.36 Explicit prescribing criteria,
such as the Screening Tool of Older Persons’ potentially
inappropriate Prescriptions (STOPP) and the Screening Tool to
Alert doctors to Right Treatment (START), can be useful in
maximising the effectiveness of drugs.37 STOPP consists of 65
indicators of potentially inappropriate prescribing in older
populations (aged ≥65 years), which have been validated in
both hospital and community settings and have been found to
be associated with adverse drug events.38 39 START comprises
22 evidence based prescriptions for long term conditions relevant
to older people.40 For younger patients, the PrescribingOptimally
in Middle Aged People’s Treatments (PROMPT) prescribing
criteria have recently been developed. Although yet to be
validated, these criteria are important steps in recognising and
dealing with treatment burden in those aged less than 65 years.41
How can organisation and continuity of
care be improved?
Patients with complex multimorbidity often see many different
healthcare providers working across multiple sites.
Communication between providers is frequently suboptimal,
which can impact negatively on patient outcomes.16 Changes in
the delivery of general practice service have reduced the
provision of continuity of care.42 43 Patients value continuity,
with over 80% of older patients (aged ≥75 years) in a recent
UK survey reporting a preference for seeing a particular doctor
in their general practice.44 Continuity of care is also associated
with improved outcomes, such as the delivery of preventive
care and reduced preventable admissions.45 46 In a recent US
study, higher levels of continuity were associated with lower
rates of hospital and emergency department visits, lower
complication rates, and less healthcare expenditure.47 General
practitioners are uniquely positioned to provide the necessary
relational, informational, and managerial continuity of care, and
the importance of this function should not be underestimated.28 48
A great strength of primary care is the access it affords patients,
and regular planned reviews may be helpful in “ordering the
chaos” for this group.49 Another key aspect for general
practitioners is rationalising specialist referrals and considering
the components of secondary care that will have most impact
on patients’ wellbeing.
Clinicians are encouraged to identify patients as having complex
multimorbidity and adopt a practice policy of continuity of care
for these patients by assigning them a named doctor.
Identification is not straightforward: the most common research
definition of multimorbidity (the presence of ≥2 conditions)
will identify large numbers of patients, many of whom will not
have particularly complex needs. Evidence is lacking to guide
practice in this area, but groups with multimorbidity and
demonstrably higher care needs include patients with “complex”
multimorbidity, defined as three or more chronic conditions
affecting three or more body systems50; patients with comorbid
physical conditions and depression51; patients prescribed 10
drugs or more8 52; and patients who are housebound or resident
in nursing homes. Practices could also consider running specific
multimorbidity clinics that address common clusters of
conditions, as there is evidence that targeting risk factors
common to comorbid conditions such as diabetes, heart disease,
and depression is effective,30 and this would also reduce
treatment burden for patients as they would need less frequent
visits.19 Currently it may not be easy for practices to identify
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such patients and this is a priority for general practice software
systems.
What measures can be used to promote
patient centred care?
Shared decision making
Shared decisionmaking has been defined as “an approach where
clinicians and patients share the best available evidence when
faced with the task of making decisions, and where patients are
supported to consider options, to achieve informed
preferences.”53 Research shows that shared decision making
improves patients’ knowledge about their condition and
treatment options, increases patient satisfaction with care, and
improves patient self confidence and self care skills.54 In the
context of multimorbidity it is first important to elicit what
matters most to the patient. Asking this at the outset of the
consultation allows the rest of the consultation to be utilised
most effectively.
A recent model has been proposed to support clinicians in
implementing shared clinical decision making in clinical
practice.55 This concerns three key steps: firstly, “choice talk,”
which refers to the step of making sure that patients know that
reasonable options are available, “option talk,” which refers to
providing more detailed information about options, and
“decision talk,” which relates to supporting the work of
considering preferences and deciding what is best. A range of
online shared decision making tools is also available to support
this process.56
Another tool named the “Adriadne principles” has recently been
developed to support decisionmaking specifically during general
practice consultations involving multimorbidity.57 This model
places the setting of realistic treatment goals at the centre of the
multimorbidity consultation and this is achieved by a thorough
interaction assessment of the patient’s conditions, treatments,
consultation, and context; the prioritisation of health problems
that take into account the patient’s preferences; and
individualised management to determine the best options of
care to achieve these goals.
In practice, asking a patient at the outset of a consultation “What
is bothering you most?” or “What would you like to focus on
today?” can help prioritise the management of aspects of care
that will have the most impact for patients. Once patient
priorities are identified, using available shared decision making
tools may help support the process.
Self management in patients with
multimorbidity
Some evidence supports lay led self management education
programmes for single chronic diseases in improving certain
outcomes, such as self efficacy and self rated health.58 The
evidence for such an approach with multimorbidity is, however,
mixed.30 Patient preference should guide the utilisation of lay
led self management groups.
The evaluation of the UK expert patient programme showed
improved self efficacy and energy levels at six month follow-up
but no reduction in healthcare utilisation.59 In a recent
randomised controlled trial in the United Kingdom general
practice staff were trained about available resources, including
an assessment tool for the support needs of patients, guidebooks
on self management, and a web based directory of local
resources. At 12 month follow-up there were no reported
improvements in shared decision making, self efficacy, or
generic health related quality of life.60
What can be achieved in a 10 minute
consultation?
Internationally, general practitioners have highlighted lack of
time as a barrier to providing care for patients with
multimorbidity.61 62 Some evidence suggests that longer
consultations result in more preventive health advice, less
prescribing, and increased patient satisfaction rates.63 However
this review was limited by the inclusion of only five older
studies with short term follow-up. In deprived areas, increased
consultation times have been shown to increase patient
enablement and reduce general practitioners’ stress.64
With demand for general practitioner services increasing, it is
difficult to schedule extra consultation time for patients with
multimorbidity. Practices may decide to flag certain patients
with complex needs to allocate longer routine consultation times,
or arrange “specific extended consultations” to allow protected
time on occasion to review chronic disease management and
drugs. Having robust practice systems in place to ensure
appropriate monitoring with the practice nurse before the
appointment with a general practitioner would facilitate the
most efficient and effective use of both patients’ and doctors’
time. Practice nurses or other multidisciplinary team members
can contribute in specific ways, including undertaking target
assessment of chronic disease and psychological or functional
capacity assessments that can support doctor and patient shared
decision making. Multidisciplinary input is an essential
component of care for these patients, and referrals to relevant
disciplines should be arranged when indicated and available.
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